World Sepsis Day 2026: join the SNIP-AFRICA – NeoSep-ADAPT Penta Aperitivo webinar on 17 September
Neonatal sepsis remains one of the leading causes of newborn death and long-term neurodevelopmental impairment worldwide, particularly across resource-limited settings. Tackling it demands research that is collaborative, adaptive, and connected across sites and disciplines, which is exactly what the SNIP-AFRICA and NeoSep-ADAPT research platforms are built to deliver. To mark World Sepsis Day 2026, join us for a special Penta Aperitivo […]
SNIP-AFRICA opens applications for second cohort of neonatal sepsis course
Following the successful launch of its flagship Neonatal Sepsis Course, the Severe Neonatal Infection Adaptive Platform Trials in Africa (SNIP-AFRICA) Consortium is now inviting applications for the second cohort of the programme. Building on the success of the first cohort, which brought together healthcare professionals and researchers from SNIP-AFRICA partner sites across Ghana, South Africa, […]
Cohort 1 of the SNIP-AFRICA Neonatal Sepsis Course: a wrap!
Neonatal sepsis remains one of the leading causes of newborn death in sub-Saharan Africa. Tackling it requires not just better diagnosis and management, but a generation of clinicians and researchers who can find the evidence, evaluate it critically and apply it in the real world. The SNIP-AFRICA Neonatal Sepsis Course was created with this goal […]
SNIP-AFRICA supports African researchers and clinicians with brand-new neonatal sepsis course
SNIP-AFRICA has launched its flagship Neonatal Sepsis Course, an important step forward in strengthening clinical care and research capacity for newborn health in sub-Saharan Africa. The first cohort of delegates consists of 16 healthcare professionals and researchers from SNIP-AFRICA’s sites in Ghana, South Africa, Tanzania and Uganda. Neonatal sepsis remains one of the leading causes […]
NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis
A paper published in the journal Antimicrobial Agents and Chemotherapy (AAC) reports that off-patent antibiotics, fosfomycin and flomoxef, when used at standard doses, were safe in newborn babies with suspected sepsis. Importantly, antibiotic levels at these doses are considered sufficient to expect good clinical effectiveness, highlighting their potential as urgently needed, affordable alternative treatments for […]
Strengthening newborn care through parent and community engagement: IHI holds workshops with parent support groups
Meaningful engagement of parents and caregivers, especially those with lived experience of newborn health challenges, is increasingly recognised as crucial for improving care, shaping research priorities, and ensuring interventions meet real community needs. As part of SNIP-AFRICA’s commitment to leveraging parent and community involvement in research, Ifakara Health Institute (IHI), our partner in Tanzania, convened […]
Neonatal sepsis surveillance activities kick off at seven African hospitals
Seven neonatal intensive care units across Ghana, Kenya, South Africa, Tanzania and Uganda have begun a two-year surveillance programme to monitor neonatal sepsis and antimicrobial resistance (AMR). The programme, which runs until mid-2027, is part of the SNIP-AFRICA project and aims to strengthen evidence on infection rates, the pathogens that cause sepsis, treatment outcomes and […]
Registrations are open for SNIP-AFRICA’s webinar: Ethics of clinical research involving children
Children are among the most vulnerable populations in clinical research. Conducting ethical paediatric clinical trials requires a careful balance between advancing medical knowledge and protecting the rights and welfare of child participants. Ethical challenges often arise around consent, risk-benefit assessment, regulatory oversight and ensuring compliance with national and international standards. We invite you to join […]
NeoSep1 trial launches to tackle drug-resistant sepsis in newborns
SNIP-AFRICA is pleased to announce a major milestone in the fight against neonatal sepsis: the launch of the NeoSep1 clinical trial, which enrolled its first newborn last week at Tygerberg Hospital in Cape Town, South Africa. NeoSep1 will evaluate novel combinations of three antibiotics – fosfomycin, flomoxef, and amikacin – against five commonly used treatment […]
Join us for SNIP-AFRICA’s first webinar: Adaptive designs in AMR research
Have you ever wanted to understand more about clinical trial designs but found the material too technical or hard to access? Whether you’re an experienced researcher, just starting out, or simply curious about trial designs, this webinar is for you. On 24 June 2025 at 16:00 CEST, SNIP-AFRICA is proud to host its very first […]
